Targeted Nanodrugs to Destroy the Tumor Extracellular Matrix Barrier for Improving Drug Delivery and Cancer Therapeutic Efficacy
Author:
Affiliation:
1. Department of Nuclear Medicine, China-Japan Union Hospital, Jilin University, Changchun 130033, China
2. National Health Commission Key Laboratory of Radiobiology, School of Public Health of Jilin University, Changchun 130033, China
Funder
Department of Science and Technology of Jilin Province
National Natural Science Foundation of China
Education Department of Jilin Province
Hygiene Specific Subjects of Jilin Province
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.2c00947
Reference48 articles.
1. Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2. Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery
3. Recent Advances in Nanostrategies Capable of Overcoming Biological Barriers for Tumor Management
4. Use of nano engineered approaches to overcome the stromal barrier in pancreatic cancer
5. Emerging concepts in pancreatic cancer medicine: targeting the tumor stroma
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Polyvinylpyrrolidone Assisted One-Pot Synthesis of Size-Tunable Cocktail Nanodrug for Multifunctional Combat of Cancer;International Journal of Nanomedicine;2024-05
2. Peptide‐Functionalized Inorganic Oxide Nanomaterials for Solid Cancer Imaging and Therapy;Advanced Materials;2024-02-23
3. Hyaluronic Acid Modified Metal Nanoparticles and Their Derived Substituents for Cancer Therapy: A Review;Pharmaceutics;2023-06-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3